Disruption of the blood-aqueous barrier and lens abnormalities in mice lacking Lysyl Oxidase-Like 1 (LOXL1)

Investigative Ophthalmology and Visual Science

Volumn 55, Issue 2, 2014, Pages 856-864

  Wiggs, Janey L ^a   Pawlyk, Basil ^a   Connolly, Edward ^a   Adamian, Michael ^a   Miller, Joan W ^a   Pasquale, Louis R ^a   Haddadin, Ramez I ^a   Grosskreutz, Cynthia L ^a   Rhee, Douglas J ^a   Li, Tiansen ^a,b  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^b NATIONAL EYE INSTITUTE   (United States)

Author keywords

Exfoliation syndrome; Glaucoma; LOXL1

Indexed keywords

EXFOLIATION SYNDROME; GLAUCOMA; LOXL1;

AMINO ACID OXIDOREDUCTASES; ANIMALS; ANTERIOR CHAMBER; BLOOD-AQUEOUS BARRIER; CATARACT; CILIARY BODY; ELASTIN; EXFOLIATION SYNDROME; FLUORESCEIN; FLUORESCEIN ANGIOGRAPHY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FLUORESCENT DYES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; IMMUNOBLOTTING; INTRAOCULAR PRESSURE; IRIS; LENS, CRYSTALLINE; MICE; MICE, INBRED C57BL; MICROSCOPY, IMMUNOELECTRON; PHENOTYPE; POLYMERASE CHAIN REACTION;

EID: 84893859685     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-13033     Document Type: Article

References (46)

1. Vesti E, Kivela T. Exfoliation syndrome and exfoliation glaucoma. Prog Retin Eye Res. 2000;19:345-368.
2. Schlotzer-Schrehardt U. Molecular pathology of pseudoexfoliation syndrome/glaucoma-new insights from LOXL1 gene associations. Exp Eye Res. 2009;88:776-785.
3. Schlotzer-Schrehardt U, Naumann GO. Ocular and systemic pseudoexfoliation syndrome. Am J Ophthalmol. 2006;141: 921-937.
4. Streeten BW, Li ZY, Wallace RN, Eagle RC, Keshgegian AA. Pseudoexfoliative fibrillopathy in visceral organs of a patient with pseudoexfoliation syndrome. Arch Ophthalmol. 1992; 110:1757-1762.
5. Ovodenko B, Rostagno A, Neubert TA, et al. Proteomic analysis of exfoliation deposits. Invest Ophthalmol Vis Sci. 2007;48: 1447-1457.
6. Creasey R, Sharma S, Gibson CT, et al. Atomic force microscopy-based antibody recognition imaging of proteins in the pathological deposits in pseudoexfoliation syndrome. Ultramicroscopy. 2011;111:1055-1061.
7. Lee RK. The molecular pathophysiology of pseudoexfoliation glaucoma. Curr Opin Ophthalmol. 2008;19:95-101.
8. Gartaganis SP, Patsoukis NE, Nikolopoulos DK, Georgiou CD. Evidence for oxidative stress in lens epithelial cells in pseudoexfoliation syndrome. Eye. 2007;21:1406-1411.
9. Sharma S, Chataway T, Burdon KP, et al. Identification of LOXL1 protein and apolipoprotein E as components of surgically isolated pseudoexfoliation material by direct mass spectrometry. Exp Eye Res. 2009;89:479-485.
10. Liu X, Zhao Y, Gao J, et al. Elastic fiber homeostasis requires lysyl oxidase-like 1 protein. Nat Genet. 2004;36:178-182.
11. Netland PA, Ye H, Streeten BW, Hernandez MR. Elastosis of the lamina cribrosa in pseudoexfoliation syndrome with glaucoma. Ophthalmology. 1995;102:878-886.
12. Pena JD, Netland PA, Vidal I, Dorr DA, Rasky A, Hernandez MR. Elastosis of the lamina cribrosa in glaucomatous optic neuropathy. Exp Eye Res. 1998. 67:517-524.
13. Streeten BW, Bookman L, Ritch R, Prince AM, Dark AJ. Pseudoexfoliative fibrillopathy in the conjunctiva. A relation to elastic fibers and elastosis. Ophthalmology. 1987;94:1439-1449.
14. Ekstr̈om C, Alm A. Pseudoexfoliation as a risk factor for prevalent open-angle glaucoma. Acta Ophthalmol. 2008;86: 741-746.
15. Ritch R. The management of exfoliative glaucoma. Prog Brain Res. 2008;173:211-224.
16. Kanthan GL, Mitchell P, Burlutsky G, Rochtchina E, Wang JJ. Pseudoexfoliation syndrome and the long-term incidence of cataract and cataract surgery: the Blue Mountains Eye Study. Am J Ophthalmol. 2013;155:83-88.
17. Summanen P, Tonjum AM. Exfoliation syndrome among Saudis. Acta Ophthalmol. 1988;184:107-111.
18. Shingleton BJ, Marvin AC, Heier JS, et al. Pseudoexfoliation: high risk factors for zonule weakness and concurrent vitrectomy during phacoemulsification. J Cataract Refract Surg. 2010;36:1261-1269.
19. Yazdani S, Tousi A, Pakravan M, Faghihi AR. Sensorineural hearing loss in pseudoexfoliation syndrome. Ophthalmology. 2008;115:425-429.
20. Schumacher S, Schlotzer-Schrehardt U, Martus P, Lang W, Naumann GO. Pseudoexfoliation syndrome and aneurysms of the abdominal aorta. Lancet. 2001;357:359-360.
21. Kuchle M, Vinores SA, Mahlow J, Green WR. Blood-aqueous barrier in pseudoexfoliation syndrome: evaluation by immunohistochemical staining of endogenous albumin. Graefes Arch Clin Exp Ophthalmol. 1996;234:12-18.
22. Schumacher S, Nguyen NX, Kuchle M, Naumann GO. Quantification of aqueous flare after phacoemulsification with intraocular lens implantation in eyes with pseudoexfoliation syndrome. Arch Ophthalmol. 1999;117:733-735.
23. Wang L, Yamasita R, Hommura S. Corneal endothelial changes and aqueous flare intensity in pseudoexfoliation syndrome. Ophthalmologica. 1999;213:387-391.
24. Thorleifsson G, Magnusson KP, Sulem P, et al. Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma. Science. 2007;317:1397-1400.
25. Fan BJ, Wiggs JL. Glaucoma: genes, phenotypes, and new directions for therapy. J Clin Invest. 2010;120:3064-3072.
26. Ozaki M, Lee KY, Vithana EN, et al. Association of LOXL1 gene polymorphisms with pseudoexfoliation in the Japanese. Invest Ophthalmol Vis Sci. 2008;49:3976-3980.
27. Williams SE, Whigham BT, Liu Y, et al. Major LOXL1 risk allele is reversed in exfoliation glaucoma in a black South African population. Mol Vis. 2010;16:705-712.
28. Kim S, Kim Y. Variations in LOXL1 associated with exfoliation glaucoma do not affect amine oxidase activity. Mol Vis. 2012; 18:265-270.
29. Fan BJ, Pasquale LR, Rhee D, Li T, Haines JL, Wiggs JL. LOXL1 promoter haplotypes are associated with exfoliation syndrome in a U.S. Caucasian population. Invest Ophthalmol Vis Sci. 2011;52:2372-2378.
30. Schl̈otzer-Schrehardt U, Pasutto F, Sommer P, et al. Genotypecorrelated expression of lysyl oxidase-like 1 in ocular tissues of patients with pseudoexfoliation syndrome/glaucoma and normal patients. Am J Pathol. 2008;173:1724-1735.
31. Zenkel M, Krysta A, Pasutto F, Juenemann A, Kruse FE, Schl̈otzer-Schrehardt U. Regulation of lysyl oxidase-like 1 (LOXL1) and elastin-related genes by pathogenic factors associated with pseudoexfoliation syndrome. Invest Ophthalmol Vis Sci. 2011;52:8488-8495.
32. Kang JH, Loomis S, Wiggs JL, Stein JD, Pasquale LR. Demographic and geographic features of exfoliation glaucoma in 2 United States-based prospective cohorts. Ophthalmology. 2012;119:27-35.
33. Stein JD, Pasquale LR, Talwar N, et al. Geographic and climatic factors associated with exfoliation syndrome. Arch Ophthalmol. 2011;129:1053-1060.
34. Liu X, Zhao Y, Pawlyk B, Damaser M, Li T. Failure of elastic fiber homeostasis leads to pelvic floor disorders. Am J Pathol. 2006;168:519-528.
35. Lee UJ, Gustilo-Ashby AM, Daneshgari F, et al. Lower urogenital tract anatomical and functional phenotype in lysyl oxidase like-1 knockout mice resembles female pelvic floor dysfunction in humans. Am J Physiol Renal Physiol. 2008;295:545-555.
36. Wood HM, Lee UJ, Vurbic D, et al. Sexual development and fertility of Loxl1-/-male mice. J Androl. 2009;30:452-459.
37. Yu HG, Liu X, Kiss S, et al. Increased choroidal neovascularization following laser induction in mice lacking lysyl oxidaselike 1. Invest Ophthalmol Vis Sci. 2008;49:2599-2605.
38. Kagan HM, Li W. Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell. J Cell Biochem. 2003;88:660-672.
39. Sasaki K, Kuriyama H, Yeh LI, Fukuda M. Studies on diabetic cataract in rats induced by streptozotocin. I. Photodocumentation of lens opacification. Ophthalmic Res. 1983;15:185-190.
40. Hoyer HE. The effect of calcium on the lens ultrastructure. Graefes Arch Clin Exp Ophthalmol. 1985;223:169-173.
41. Shearer TR, Anderson RS. Histologic changes during selenite cataractogenesis: a light microscopy study. Exp Eye Res. 1985; 40:557-565.
42. Wang-Su ST, McCormack AL, Yang S, et al. Proteome analysis of lens epithelia, fibers, and the HLE B-3 cell line. Invest Ophthalmol Vis Sci. 2003;44:4829-4836.
43. Gelman S, Cone FE, Pease ME, Nguyen TD, Myers K, Quigley HA. The presence and distribution of elastin in the posterior and retrobulbar regions of the mouse eye. Exp Eye Res. 2010; 90:210-215.
44. Yagci R, Ersoz I, Erdurmus M, Gurel A, Duman S. Protein carbonyl levels in the aqueous humour and serum of patients with pseudoexfoliation syndrome. Eye. 2008;22:128-131.
45. Gartaganis SP, Georgakopoulos CD, Patsoukis NE, Gotsis SS, Gartaganis VS, Georgiou CD. 2005. Glutathione and lipid peroxide changes in pseudoexfoliation syndrome. Curr Eye Res. 2005;30:647-651.
46. Bleich S, Roedl J, Von Ahsen N, et al. Elevated homocysteine levels in aqueous humor of patients with pseudoexfoliation glaucoma. Am J Ophthalmol. 2004;138:162-164.